Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSTPIP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NDUFB10 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | C1orf131 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | EIF5AL1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | BCL7A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | C2CD4D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CKS1B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CD52 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | KHDRBS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CTC-554D6.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |